stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Edgewise Therapeutics IncEWTX
$38.290.47%0.18

Edgewise Therapeutics Inc (EWTX)

Date: 2026-11-03 16:00O: 38.73H: 40.41L: 36.70C: 38.29Vol: 930.5k
Schlusskurs vom Vortag:
$38.11
Offen:
$38.73
24-Stunden-Volumen:
938,370
Relatives Volumen:
0.72
Marktkapitalisierung:
$4.16B
Einnahmen:
-
Nettoeinkommen (Verlust:
-$176.01M
KGV:
-
EPS:
-$1.66
Netto-Cashflow:
-$148.97M
1W Leistung:
-3.14%
1M Leistung:
-7.51%
6M Leistung:
+25.09%
1Y Leistung:
+113.08%
1-Tages-Spanne:
$36.70$40.41
1-Wochen-Bereich:
$37.46$41.63
52-Wochen-Spanne:
$16.70$48.51

Edgewise Therapeutics Inc Aktie (EWTX) Unternehmensprofil

Firmenname
Edgewise Therapeutics Inc
Telefon
720-262-7002
Adresse
1715 38TH ST, BOULDER, USA
Mitarbeiter
146
X
-
Nächster Verdiensttermin
2026-11-05
Neueste SEC-Einreichungen
SEC
EWTX-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Edgewise Therapeutics Inc Aktie (EWTX) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-10-16EingeleitetWilliam BlairOutperform
2026-07-09EingeleitetOppenheimerOutperform
2025-09-25EingeleitetGoldmanNeutral
2025-07-30EingeleitetRaymond JamesStrong Buy

Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)151.39126.9790.9154.0332.19
Operating expenses USD (M)191.41158.83114.3671.6643.22
Operating income USD (M)-191.41-158.83-114.36-71.66-43.22
Income before tax USD (M)-167.80--100.16-67.64-42.81
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-167.80-133.81-100.16-67.64-42.81
Basic EPS USD/shares-1.63-1.45-1.57-1.26-1.14
Diluted EPS USD/shares-1.63-1.45-1.57-1.26-1.14
Basic weighted shares shares (M)102.9392.4163.7253.5937.53
Diluted weighted shares shares (M)102.9392.4163.7253.5937.53

Edgewise Therapeutics Inc-Aktie (EWTX) Insiderhandel

  • JOANNE DONOVANAug 13 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $43.56
    #Aktien
    2,919
    Wert ($)
    127,152
    #Aktien Gesamt
    0
  • CMO
    Transaktion
    Sale
    Kosten
    $43.41
    #Aktien
    2,919
    Wert ($)
    126,704
    #Aktien Gesamt
    8,625
  • MOORE JOHN RAug 12 '26
    General Counsel
    Transaktion
    Sale
    Kosten
    $43.82
    #Aktien
    5,016
    Wert ($)
    219,823
    #Aktien Gesamt
    17,697
  • Chief Business Officer
    Transaktion
    Option Exercise
    Kosten
    $0.00
    #Aktien
    13,281
    Wert ($)
    0
    #Aktien Gesamt
    36,926
  • Chief Business Officer
    Transaktion
    Sale
    Kosten
    $43.81
    #Aktien
    5,100
    Wert ($)
    223,424
    #Aktien Gesamt
    31,826
  • KOCH KEVINAug 12 '26
    President and CEO
    Transaktion
    Option Exercise
    Kosten
    $0.00
    #Aktien
    39,844
    Wert ($)
    0
    #Aktien Gesamt
    70,459
  • KOCH KEVINAug 12 '26
    President and CEO
    Transaktion
    Sale
    Kosten
    $43.68
    #Aktien
    17,971
    Wert ($)
    785,042
    #Aktien Gesamt
    52,488
  • Russell Alan JAug 12 '26
    Chief Scientific Officer
    Transaktion
    Sale
    Kosten
    $43.73
    #Aktien
    5,901
    Wert ($)
    258,042
    #Aktien Gesamt
    31,466
  • MOORE JOHN RAug 12 '26
    General Counsel
    Transaktion
    Option Exercise
    Kosten
    $0.00
    #Aktien
    12,499
    Wert ($)
    0
    #Aktien Gesamt
    22,713
  • CMO
    Transaktion
    Sale
    Kosten
    $43.85
    #Aktien
    6,522
    Wert ($)
    286,000
    #Aktien Gesamt
    11,544
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
JOANNE DONOVANOfficerAug 13 '26Proposed Sale$43.562,919127,1520
Donovan Joanne M.CMOAug 13 '26Sale$43.412,919126,7048,625
MOORE JOHN RGeneral CounselAug 12 '26Sale$43.825,016219,82317,697
Derakhshan BehradChief Business OfficerAug 12 '26Option Exercise$0.0013,281036,926
Derakhshan BehradChief Business OfficerAug 12 '26Sale$43.815,100223,42431,826
KOCH KEVINPresident and CEOAug 12 '26Option Exercise$0.0039,844070,459
KOCH KEVINPresident and CEOAug 12 '26Sale$43.6817,971785,04252,488
Russell Alan JChief Scientific OfficerAug 12 '26Sale$43.735,901258,04231,466
MOORE JOHN RGeneral CounselAug 12 '26Option Exercise$0.0012,499022,713
Donovan Joanne M.CMOAug 12 '26Sale$43.856,522286,00011,544

Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten

Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Apr 01, 2026
Apr 01, 2026
Sep 23, 2026
Sep 23, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 22, 2026
Sep 22, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 13, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 04, 2026
Sep 04, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 01, 2026
Sep 01, 2026
Aug 31, 2026
Aug 31, 2026
Aug 24, 2026
Aug 24, 2026
Aug 23, 2026
Aug 23, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 16, 2026
Aug 16, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026
Aug 15, 2026

Ähnlich wie EWTX